18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: Case-series and literature review

Amyloid

Volumn 19, Issue 2, 2012, Pages 94-98

  Mekinian, Arsene ^a   Jaccard, Arnaud ^b   Soussan, Michael ^a   Launay, David ^c   Berthier, Sabine ^d   Federici, Laure ^e   Lefèvre, Guillaume ^c   Valeyre, Dominique ^a   Dhote, Robin ^a   Fain, Olivier ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c UNIV LILLE   (France)

^d HÔPITAL DU BOCAGE   (France)

^e Pasteur Hospital   (France)

Author keywords

AL amyloidosis; Diagnosis; FDG PET

Indexed keywords

AMYLOID; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; AMYLOIDOSIS; BONE; CASE STUDY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; DUODENUM; FEMALE; FOLLOW UP; HUMAN; LUNG; MALE; MESENTERY; MUSCLE; NASOPHARYNX; PLASMACYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; WALDENSTROEM MACROGLOBULINEMIA;

AGED; AGED, 80 AND OVER; AMYLOID; AMYLOIDOSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES;

EID: 84861626904     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2012.682833     Document Type: Review

References (21)

1. Pepys MB. Pathogenesis, diagnosis and treatment of systemic amyloidosis. Philos Trans R Soc Lond, B, Biol Sci 2001;356:203-10; discussion 210.
2. Hawkins PN. Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr Opin Nephrol Hypertens 2002;11:649-655.
3. Bartel TB, Haessler J, Brown TL, Shaughnessy JD Jr, van Rhee F, Anaissie E, Alpe T, et al. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood 2009;114:2068-2076.
4. Kung J, Zhuang H, Yu JQ, Duarte PS, Alavi A. Intense fluorodeoxyglucose activity in pulmonary amyloid lesions on positron emission tomography. Clin Nucl Med 2003;28:975-976.
5. Ollenberger GP, Knight S, Tauro AJ. False-positive FDG positron emission tomography in pulmonary amyloidosis. Clin Nucl Med 2004;29:657-658.
6. Currie GP, Rossiter C, Dempsey OJ, Legge JS. Pulmonary amyloid and PET scanning. Respir Med 2005;99:1463-1464.
7. Grubstein A, Shitrit D, Sapir EE, Cohen M, Kramer MR. Pulmonary amyloidosis: detection with PET-CT. Clin Nucl Med 2005;30:420-421.
8. Yadav S, Sharma S, Gilfillan I. Unusual positron emission tomography findings in pulmonary amyloidosis: a case report. J Cardiothorac Surg 2006;1:32.
9. Yoshida A, Borkar S, Singh B, Ghossein RA, Schoder H. Incidental detection of concurrent extramedullary plasmacytoma and amyloidoma of the nasopharynx on [18F]fluorodeoxyglucose positron emission tomography/computed tomography. J Clin Oncol 2008; 26:5817-5819.
10. Seo JH, Lee SW, Ahn BC, Lee J. Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT. Lung Cancer 2010;67:376-379.
11. Costantino F, Loeuille D, Dintinger H, Pere P, Chary-Valckenaere I. Fixed digital contractures revealing light-chain amyloidosis. Joint Bone Spine 2009;76:553-555.
12. Tan H, Guan Y, Zhao J, Lin X. Findings of pulmonary amyloidosis on dual phase FDG PET/CT imaging. Clin Nucl Med 2010;35: 206-207.
13. Mainenti PP, Segreto S, Mancini M, Rispo A, Cozzolino I, Masone S, Rinaldi CR, et al. Intestinal amyloidosis: two cases with different patterns of clinical and imaging presentation. World J Gastroenterol 2010;16:2566-2570.
14. Mekinian A, Ghrenassia E, Pop G, Roberts S, Prendki V, Stirnemann J, Weinmann P, Fain O. Visualization of amyloid arthropathy in lightchain systemic amyloidosis on F-18 FDG PET/CT scan. Clin Nucl Med 2011;36:52-53.
15. Soussan M, Ouvrier MJ, Pop G, Galas JL, Neuman A, Weinmann P. Tracheobronchial FDG uptake in primary amyloidosis detected by PET/ CT. Clin Nucl Med 2011;36:723-724.
16. Son YM, Choi JY, Bak CH, Cheon M, Kim YE, Lee KH, Kim BT. 18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma. Korean J Radiol 2011;12:634-637.
17. Gertz M, Comenzo R, Falk R, Fermand JP. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis: a consensus opinion from 10th international symposium on amyloid and amyloidosis. Am J Haematol 2005;79:319-328.
18. Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol 2008;190:W151-W156.
19. Langah R, Spicer K, Gebregziabher M, Gordon L. Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol 2009;16:801-810.
20. Rabinovici GD, Furst AJ, O'Neil JP, Racine CA, Mormino EC, Baker SL, Chetty S, et al. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology 2007; 68:1205-1212.
21. Wall JS, Kennel SJ, Stuckey AC, Long MJ, Townsend DW, Smith GT, Wells KJ, et al. Radioimmunodetection of amyloid deposits in patients with AL amyloidosis. Blood 2010;116:2241-2244.